Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Jones

Showing results (351-360 of 363) with videos related to

Pageof 37
Sort By:
The Lancet. Oncology|December 7, 2019
Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trialJoaquin Mateo, Nuria Porta, Diletta Bianchini, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 20, 2023
The multi-societal European consensus on the terminology, diagnosis and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSEAjith K Siriwardena, Alejandro Serrablo, Åsmund A Fretland, et al.
The British Journal of Surgery|July 13, 2023
Multisocietal European consensus on the terminology, diagnosis, and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSEAjith K Siriwardena, Alejandro Serrablo, Åsmund Avdem Fretland, et al.
Faraday Discussions|December 5, 2017
Ionic liquids at interfaces: general discussionAndrew Abbott, Matthew Addicoat, Leigh Aldous, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
A Lung Cancer Mouse Model DatabaseLing Cai, Ying Gao, Ralph J DeBerardinis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2023
ALK Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult GlioblastomaAnne-Florence Blandin, Ross Giglio, Maya Srikanth Graham, et al.
European Urology Focus|May 4, 2019
Clinical and Patient-reported Outcome Measures in Men Referred for Consideration of Surgery to Treat Lower Urinary Tract Symptoms: Baseline Results and Diagnostic Findings of the Urodynamics for Prostate Surgery Trial; Randomised Evaluation of Assessment Methods (UPSTREAM)Amanda L Lewis, Grace J Young, Paul Abrams, et al.
The New England Journal of Medicine|October 29, 2015
DNA-Repair Defects and Olaparib in Metastatic Prostate CancerJoaquin Mateo, Suzanne Carreira, Shahneen Sandhu, et al.
Neuroimage|May 31, 2022
Insights from the IronTract challenge: Optimal methods for mapping brain pathways from multi-shell diffusion MRIChiara Maffei, Gabriel Girard, Kurt G Schilling, et al.
The Lancet. Oncology|July 10, 2025
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocolSilke Gillessen, Laura Murphy, Nicholas D James, et al.
Pageof 37

Showing results (351-360 of 363) with videos related to

Sort By:
Pageof 37
The Lancet. Oncology|December 7, 2019
Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trialJoaquin Mateo, Nuria Porta, Diletta Bianchini, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 20, 2023
The multi-societal European consensus on the terminology, diagnosis and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSEAjith K Siriwardena, Alejandro Serrablo, Åsmund A Fretland, et al.
The British Journal of Surgery|July 13, 2023
Multisocietal European consensus on the terminology, diagnosis, and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSEAjith K Siriwardena, Alejandro Serrablo, Åsmund Avdem Fretland, et al.
Faraday Discussions|December 5, 2017
Ionic liquids at interfaces: general discussionAndrew Abbott, Matthew Addicoat, Leigh Aldous, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
A Lung Cancer Mouse Model DatabaseLing Cai, Ying Gao, Ralph J DeBerardinis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2023
ALK Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult GlioblastomaAnne-Florence Blandin, Ross Giglio, Maya Srikanth Graham, et al.
European Urology Focus|May 4, 2019
Clinical and Patient-reported Outcome Measures in Men Referred for Consideration of Surgery to Treat Lower Urinary Tract Symptoms: Baseline Results and Diagnostic Findings of the Urodynamics for Prostate Surgery Trial; Randomised Evaluation of Assessment Methods (UPSTREAM)Amanda L Lewis, Grace J Young, Paul Abrams, et al.
The New England Journal of Medicine|October 29, 2015
DNA-Repair Defects and Olaparib in Metastatic Prostate CancerJoaquin Mateo, Suzanne Carreira, Shahneen Sandhu, et al.
Neuroimage|May 31, 2022
Insights from the IronTract challenge: Optimal methods for mapping brain pathways from multi-shell diffusion MRIChiara Maffei, Gabriel Girard, Kurt G Schilling, et al.
The Lancet. Oncology|July 10, 2025
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocolSilke Gillessen, Laura Murphy, Nicholas D James, et al.
Pageof 37